Second-line immunotherapy in new onset refractory status epilepticus. Hanin A, Muscal E, Hirsch LJ. Epilepsia 2024 Mar 2. doi: 10.1111/epi.17933.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hanin A, Muscal E, Hirsch LJ. Second-line immunotherapy in new onset refractory status epilepticus. Epilepsia 2024 Mar 2. doi: 10.1111/epi.17933.
PMID: 38430119